NOVT (novanta.com) צמיחת רווח נקי למניה השנה

Leveraging its experience in retaining leading optical engineers, Novanta Inc. is developing surgical robotics. The GURU.Markets portal features a chart where the percentage of EPS deviation from last year's level illustrates the current situation, and the 11.90 level serves as a critical benchmark. In the future, the integration of lasers into diagnostics will ensure predictable FCF and stable demand, creating a highly reliable source of recurring revenue.

To assess the long-term sustainability of Novanta Inc. (NOVT), calculating the annual change in earnings per share is critical, as it measures the net income growth rate relative to the previous year. The current proportional EPS growth compared to last year stands at 11.90, confirming the company's ability to convert deep integration into medical equipment into stable financial results and high business margins.